At a glance

ClinicalIndex Comparison Record

N/ACompleted· 108 enrolled

Drug / intervention

DOT mobile appother

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04633200

NCT04633200N/ACompleted

Compare CT.gov

Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM

Environment and Health Group, Inc.·interventional·Posted Nov 18, 2020·Updated Dec 28, 2023

In Brief

A clinical study evaluating DOT mobile app for Hiv. Completed, enrolled 108 participants across 1 site.

Detailed Summary

This Phase 2 project aims to enhance and test a mobile health intervention designed to increase adherence to the daily PrEP pill among culturally-diverse young adult men who have sex with men. The intervention will include: a) personalized PrEP pill reminders b) culturally- and developmentally-sensitive text messages targeting patient education, motivation, and stress c) a gamification avatar and d) a linked online community of peers. Effectively promoting PrEP adherence would reduce new HIV infections in this at-risk population, which is subject to health disparities

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsHiv

CountriesUnited States

Collaborators--

Timeline

N/ACompletedFinished

202120222023202420252026

First PostedNov 2020

Enrollment StartFeb 2021

Primary CompletionJun 2022

Study CompletionJul 2022

TodayJul 2026

First PostedNov 18, 2020

Enrollment StartFeb 1, 2021

Primary CompletionJun 30, 2022

Study CompletionJul 30, 2022

TodayJul 2, 2026

Enrollment to primary: 1.4 yearsPosted 5.6 years ago

Interventions

DOT mobile appother

DOT is a mobile phone app that has daily pill reminders and supportive texts, as well as various features designed to support PrEP medication adherence.